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The association between an area-based measure of depriva- 
tion and survival from the I0 most common cancers was studied 
in 155,682 patients diagnosed between 1980 and 1989 in the 
area covered by the South Thames Regional Health Authority. 
Furthermore, the impact of stage of disease at diagnosis on this 
association was studied. The measure of deprivation was the 
Carstairs Index of the census enumeration district of each 
patient’s residence at diagnosis (5 categories) and the cancers 
studied were: lung, breast, colorectum, bladder, prostate, 
stomach, pancreas, ovary, uterus and cervix. In the univariate 
analyses the measure of outcome was the relative survival rate 
and in the multivariate analyses it was the hazard ratio. Both 
univariate and multivariate analyses showed that patients from 
affluent areas had better survival than patients from deprived 
areas for cancers of the lung, breast, colorectum, bladder, 
prostate, uterus and cervix. Stage of disease at diagnosis did not 
explain the survival differences by deprivation category. For 
cancers of the stomach, pancreas and ovary, no variation in 
survival by deprivation category was found. For most cancer 
sites, a clear gradient in survival by deprivation category was 
observed, which implies a large potential reduction of cancer 
mortality among the lower socioeconomic groups. Future stud- 
ies need to incorporate other possible explanatory factors, 
besides stage, of the association between deprivation and 
survival. 
o 1995 Wiley-Liss, Inc. 
The association between socioeconomic status and cancer 
mortality has been studied for many years (Logan, 1982). 
Attempts to explain the variation in cancer mortality rates 
between socioeconomic groups have mainly focused on study- 
ing socioeconomic variation in cancer incidence and the 
distribution of cancer-risk factors across groups. The varia- 
tions in cancer survival and its possible determinants, for 
example, socioeconomic differences in the timing of cancer 
detection and treatment, have been studied less intensively 
(Kogevinas, 1990; Schrijvers and Mackenbach, 1994). Neverthe- 
less, the potential for reduction of cancer mortality among the 
socioeconomically disadvantaged, by improving such factors as 
early detection and adequate treatment, seems promising, and 
socioeconomic variation in cancer survival should be moni- 
tored systematically. We therefore examined the association 
between an area-based measure of deprivation and cancer 
survival in the 10 most common cancers in the area covered by 
the South Thames Regional Health Authority (RHA). 
The most recent studies that have dealt with the association 
between deprivation and survival in a large number of common 
cancers have not studied the impact of stage of disease at 
diagnosis on this association (VQgero and Persson, 1987; 
Kogevinas ef  al., 1991). We were able to study the impact of 
stage of disease at diagnosis, an important prognostic factor, 
which may point to socioeconomic variation in the early 
detection of cancer. 
PATIENTS AND METHODS 
Patients 
Data for this study came from the records of the Thames 
Cancer Registry, a population-based cancer registry covering a 
population of about 14 million people in south-east England. 
From 1960 to 1984 the registry covered the territory of the 
South Thames RHA; in 1985 coverage was extended to include 
the territory of the North Thames RHA. In this analysis, 
patients diagnosed from 1980 were studied and therefore only 
patients resident in South Thames R H A  were included for 
study. The methods and data quality indices of the Registry 
have been described (Skeet, 1991) and incidence for the 1980s 
reported (Skeet et al., 1987; Chamberlain et al., 1993; Thames 
Cancer Registry, 19920,b). 
The records of all patients (men and women) diagnosed 
between 1980 and 1989 with a malignant tumour in one of the 
10 most common cancer sites and aged 30 to 99 years at 
diagnosis were checked (n = 192,082). The cancers included 
were lung, breast, colorectum, bladder, prostate, stomach, 
pancreas, ovary, uterus and cervix. Two categories of patients 
were excluded from the analyses: patients with an incomplete 
or unknown postcode (n = 11,495 or 6%), since their census 
enumeration district could not be reliably determined (see 
below). The survival of these patients did not differ substan- 
tially from the survival of patients included in the analysis. 
Patients for whom the date of death was known but not the 
date of diagnosis (death certificate only cases, DCO) were also 
excluded from analyses, as their survival time could not be 
calculated (n = 24,905 or 13%). A total of 155,682 (81% of the 
original data set) were included in the survival analyses: 73,444 
men and 82,238 women (Table I ) .  
Deprivation score 
The measure of deprivation for each patient was based on 
the address at time of diagnosis, by linking the full postcode of 
residence to the corresponding census enumeration district. 
Data from the 1981 census on 4 indicators of material 
deprivation were obtained for each enumeration district (aver- 
age of 400 households in Great Britain): overcrowding (propor- 
tion of persons in private households living at a density of more 
than one person per room); male unemployment (proportion 
of economically active males seeking work); low social class 
(proportion of all persons in private households with head of 
household in social class IV or V); and car ownership (propor- 
tion of all persons in private households without a car). 
The Carstairs Index combines standardized scores on these 
4 variables into a single score for each census enumeration 
district (Carstairs and Morris, 1991), using the mean value and 
standard deviation for Great Britain as a standard. 
Each of the 14,386 enumeration districts in South Thames 
RHA was assigned to  one of 5 deprivation categories, which 
were constructed by ranking the Carstairs scores for all 
enumeration districts in Great Britain from low (“affluent”) to 
high (“deprived”), and by forming quintiles based on the 
underlying population distribution. 
Prognostic factors 
Age was studied in 2 or 3 categories, depending on the 
age-distribution of cases for each cancer: lung, bladder and 
stomach (30-64, 65-74 and 75-99), breast, ovary, uterus and 
pancreas (30-64 and 65-99), colorectum and prostate (30-74 
and 75-99), and cervix (30-44, 45-64 and 65-99). The results 
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TABLE I - NUMBER (PERCENTAGE) OF PATIENTS BY CANCER AND DEPRIVATION CAEEGORY. 10 MOST 
COMMON CANCERS. MEN AND WOMEN, SOUTH THAMES RHA. 198&1989 
Deprivation category 
2 3 4 
Total S 
(Deorivedl 
Cancer 1 
(Affluenll 
Lung 10,088 (25.0) 9,160 (22.7) 8,989 (22.3 8,223 (20.4) 3,819 (9.5) 40,279 
Breast 6,107 (20.61 4,536 115.31 1,789 16.0) 29,676 
6,002 (21.6 4,662 16.8 1,701 6.1) 27,796 
2,809 (21.7 2 282 17.6 905 7.0 12,957 
2,414 (22.1) 2,200 20.1 929 8.5 10,931 
2,524 (20.1)) 1:852 114.81 723 i5.81 12,532 
Pancreas 1,979 1,438 (21.2) 1,203 117.81 486 17.2 6,772 I Ovary 1,994 33.2 1491 24 8 1,216 (20.3 916 15.3 382 (6.4 5,999 Uterus 1,537 130.91 1:261 [25:41 1,064 (21.4 775 15.6 331 6.7 4,968 
Cervix 935 24.8) 805 (21.3 856 (22.4 763 i20.2l 413 i10.9) 3,772 
Total 46.039 129.6) 37,334 (24.0) 33,419 (21.5) 27,412 (17.6 11,478 (7.4) 155,682 
of analyses in which age was studied in much smaller catego- 
ries did not differ from those presented in this report. Data for 
men and women were combined for cancers of the lung, 
colorectum, stomach and pancreas, as both overall survival and 
the gradient in survival by deprivation were very similar. 
Gender was included as a possible confounder for these 
cancers. Survival from bladder cancer was clearly higher for 
men than for women, therefore we will also discuss the results 
for this cancer for men and women separately. Period of 
diagnosis was included in the analysis in 2 5-year periods: 1980 
to 1984 and 1985 to 1989. Stage at diagnosis (clinical or 
pathological) was explicitly stated in 20% of the medical 
records for all cancers combined. A simplified stage is rou- 
tinely constructed by Registry staff for all cases, however, using 
pathology reports, operation notes and other information. 
Stage was originally categorized in 3 groups: local (tumour 
confined to the organ of origin); regional (involvement of 
regional lymph nodes) and metastasis (spread to distant 
organs). Patients for whom the stage at diagnosis was unknown 
were also included in the analysis as a fourth category. For 
most of the cancers, the percentage of patients diagnosed with 
a regional disease was rather low, and therefore the 4 catego- 
ries of stage were distinguished only for cancers of the lung, 
breast, colorectum and stomach. For the other cancers, the 
distinction was local, non-local (regional and metastasis com- 
bined), and unknown. Data for cancers of the colon and 
rectum were combined, and adjustment was made for sub-site 
in 5 categories: (1) rectum, (2) sigmoid, (3) ascending colon, 
(4) transverse and descending colon, and ( 5 )  other sub-sites. 
Furthermore, sub-sites were distinguished for stomach cancer: 
(1) cardia, ( 2 )  pylorus, (3) stomach excluding cardia and 
pylorus. 
Survival analysis 
Cases diagnosed between 1980 and 1989 were followed up 
until the date of death or 31 December 1992, whichever 
occurred first. 
To adjust for mortality from causes other than the cancer 
under study, we used the relative survival rate as measure of 
outcome in the univariate analyses. The relative survival rate, 
expressed as a percentage (RSR%) is the ratio of observed 
survival in a group of cancer patients to the survival that would 
be expected if they were subject to the same overall mortality 
rates by age, gender and calendar period as the general 
population (Cutler and Ederer, 1958). The England and Wales 
life tablc for 1981 was used to calculate expected survival. The 
RSR and its 95% confidence interval (CI) were calculated by a 
computer program from the Finnish Cancer Registry (Haku- 
linen and Abeywickrama, 1985). 
In the multivariate analyses, the measure of outcome was 
the hazard ratio which expresses the probability of death from 
the cancer under study for a specific category of patients 
relative to a reference category (which has a hazard ratio of 
unity). These analyses were conducted with a proportional- 
hazards model adapted to the RSR (Hakulinen and Tenkanen, 
1987) using GLIM (Payne, 1985). 
We started with a basic model which included duration of 
follow-up in 2 categories (up to 5 years, and 6 to 13 years) and 
deprivation category, and then added the other variables (age, 
gender, period of diagnosis, stage at diagnosis and sub-site for 
colorectal and stomach cancer). The improvement in fit due to 
each variable was tested for statistical significance at the 5% 
level with the Chi-square test. The statistical significance of the 
trend in the hazard ratio across deprivation categories was 
tested by examining the effect of adding deprivation category 
to the model as a continuous variable (one degree of freedom). 
RESULTS 
About 30% of all patients lived in areas categorized as the 
most affluent quintile of the Carstairs Index, while only 7.4% 
lived in areas categorized as the most deprived quintile. This 
distribution reflects the relative affluence of South Thames 
within Great Britain. For a few cancers, the percentage of 
patients in the 2 most affluent groups is higher than the 
percentage for all cancers combined: these are breast, prostate 
and ovary, and to a lesser extent colorectum and uterus. For 
cancers of the lung, stomach and cervix, the percentage of 
patients in the 2 most deprived categories is higher than the 
percentage for all cancers combined. For cancers of the 
bladder and pancreas, there was a similar distribution across 
deprivation categories as for all cancers combined. This 
variation in the distribution of patients across deprivation 
categories per cancer as compared with all cancers combined 
probably reflects variation in incidence by deprivation category 
(Table I ) .  
Relative survival 5 years after diagnosis was better for 
patients from affluent areas than for patients from deprived 
areas for cancers of the lung, breast, colorectum, bladder, 
prostate, uterus and cervix. For these cancers we observed a 
gradient in survival by deprivation, which was interrupted in 
the second lowest category of deprivation for cancers of the 
lung, breast, prostate, uterus and cervix. The gradient in 
survival by deprivation for bladder cancer was present only in 
men (5-year RSR%: affluent (1) 69, (2) 67, (3) 66, (4) 63, 
deprived ( 5 )  62), but not in women. For cancers of the 
stomach, pancreas and ovary, no clear difference in 5-year 
RSR% by deprivation category was observed (see Fig. 1 and 
Appendix). 
For each of the cancers we saw a similar gradient in 10-year 
RSR% by deprivation category as for the 5-year RSR% 
(results not shown). For cancers with an overall 5-year RSR% 
below 20 (pancreas, lung, stomach), we also examined the 
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FIGURE 1 - Five-year relative survival rate (RSR%), by cancer 
and deprivation category, 10 most common cancers, South Thames, 
1980-1989. (a) Lung; (b) breast; (c )  colorectum; (d) bladder; (e) 
prostate; (f) stomach; (g) pancreas; (h) ovary; (i) uterus; 0) cervix. 
APPENDIX TABLE 1 - FIVE-YEAR RSRS;. BY DEPRIVATION C A E G O R Y  AND CANCER (SEE FIG. 1) 
5 
(Denrivedl 2 3 4 
1 
fAffluent) 
Lung 8.0 7.3 7.2 6.3 6.5 
Breast 71 67 63 64 60 
Colorectum 40 41 39 36 36 
Bladder 66 65 63 62 61 
Prostate 52 48 45 40 42 
Stomach 11 12 10 12 12 
Pancreas 
Ovarv 
3.8 3.3 4 3.6 4.5 
30 27 27 30 27 
IJ terk 76 71 71 66 67 
Cervix 62 5 1  55 58 54 
survival gradient by deprivation, 1 and 2 years after diagnosis. 
For cancer of the pancreas, we observed a higher 1-year 
RSR% in affluent patients than in deprived patients, but 2 
years after diagnosis the gradient had disappeared. For lung 
and stomach cancer, the results for survival 1 and 2 years after 
diagnosis were similar to those for survival 5 and 10 years after 
diagnosis (results not shown). 
The stage distribution by cancer and deprivation category 
showed no systematic pattern for most cancers. Only for breast 
cancer, and to a lesser degree for cancer of the prostate, we 
found a higher percentage of patients with non-local disease in 
the more deprived patient groups (Table 11). 
Table I11 shows the results from the multivariate analyses, 
by cancer and deprivation category. The hazard ratios pre- 
sented in this table were adjusted for follow-up period, age, 
gender, period of diagnosis and sub-site in colorectal and 
stomach cancer. These hazard ratios combine results for the 
entire period of follow-up, so for example the hazard ratio of 
1.13 for the most deprived category of lung-cancer patients 
means that during the entire period of follow-up, the annual 
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TABLE I1 - PERCENTAGE OF PATIENTS WITH NON-LOCAL STAGE AT 
DIAGNOSIS BY CANCER AND DEPRIVATION CATEGORY, 10 MOST 
COMMON CANCERS. SOUTH THAMES RHA, 1980-1989 
Deprivatlon category 
Cancer 1 5 Total 
1 (Affluent) ' (Deprived) 
Lung 30.3 30.9 29.1 28.9 29.3 29.8 
Breast 29.5 31.2 30.5 32.2 35.5 30.9 
Colorectum 32.6 33.2 32.6 31.9 32.2 32.6 
Bladder 4.6 4.7 5.1 5.1 4.8 4.8 
Prostate 26.8 26.3 28.3 27.8 31.4 27.4 
Stomach 37.3 36.7 36.4 36.5 35.3 36.6 
Pancreas 31.4 33.6 34.9 30.2 29.8 32.3 
Ovary 36.1 39.4 43.2 39.1 31.4 39.1 
Uterus 9.6 10.5 9.1 11.4 6.6 9.8 
Cervix 10.1 11.6 12.4 10.2 13.6 11.3 
exccss probability of dying was 13% in the most dcprived 
category as compared with thc most affluent category (Table 
The results from the multivariate analyses are in agreement 
with the results from thc univariate analyses: the hazard ratios 
wcre highcr in thc more deprived categories for cancers of the 
lung, breast, colorectum, bladder, prostate, uterus and cervix. 
The trend in hazard ratios by deprivation was statistically 
significant for these cancers. For cancers of the stomach, 
pancreas and ovary, no clear gradient in hazard ratios by 
deprivation category was observed, and the trend in hazard 
ratios by deprivation was not statistically significant. 
We tested the improvement of fit of the preceding model 
resulting from the addition of stage, which was statistically 
significant for each of the cancers. However, the addition of 
stage caused no large changes in the hazards for the 5 
deprivation categories in most cancers (Table IV). The changes 
in hazard ratios for deprivation were largest for cancers of the 
utcrus and cervix, especially in the most deprived patient 
group. For cervical cancer, the hazard ratio for the most 
deprived patient group changed from 1.35 to 1.27 and for 
cancer of the uterus from 1.46 to 1.59. 
111). 
DISCUSSION 
Our results show that patients from deprived areas had 
worse survival than those from affluent areas for cancers of the 
lung, breast, colorectum, bladder, prostate, uterus and cervix, 
but not for cancers of the stomach, pancreas or ovary. The 
excess hazard of death for patients from the most deprived 
category ranged from 11 %' for colorectal and lung cancer to 
59% for cancer of the uterus (adjusted for age, gender, period 
of diagnosis and stage at diagnosis). This shows an enormous 
potential for a reduction of cancer mortality by improving the 
survival rates of patients from deprived areas. Stage of disease 
at diagnosis was not an important explanatory factor of the 
association between deprivation and survival. 
We considered a number of methodological aspects that 
might have influenced our  results. First, we used an area-based 
measure of deprivation (Carstairs Index), which is a proxy 
measure of the deprivation of individual cancer patients. We 
did not use social class based on occupation as measure of 
deprivation, since this was incompletc or missing for a large 
proportion of patients, especially for women. Furthermore, 
deprivation was found to be more strongly associated with 
mortality than social class based on occupation (Carstairs and 
Morris, 1989). On the other hand, using an area-based 
measure could result in misclassification and therefore in 
underestimation of the gradient in survival by deprivation. For 
most cancers, our results were similar to those from another 
English study in which an individual measure of deprivation 
was used (Kogevinas et al., 1991). Better survival for patients 
with a low socioeconomic status was found in this study for 
cancers of the prostate, breast, and stomach and rectum in 
females. If the association between deprivation and survival 
for these cancers had been underestimated in our study as a 
result of misclassification, the findings from both studies on 
these cancers would be even more divergent. 
Second, DCO cases were excluded from the analyses. 
However, the percentage of such cases varied systematically 
only across deprivation categories for lung cancer, with a 
higher DCO% in more dcprived categories (Table V). We 
were able to estimate the effect of DCO cases on observed 
lung-cancer survival, as the date of diagnosis of as many DCO 
cases as possible diagnosed during 1986-1987 had been ob- 
tained through the Family Health Service authorities. The 
survival of these cases could therefore be calculated and the 
ratio of survival reduction (%) to DCO (%) was used to 
estimate the impact of DCO bias on our results (J. Bullard, 
personal communication). The ratio of the observed 5-year 
survival rate in the most affluent group and the observed 5-year 
survival rate in groups 2 to 5 of lung-cancer paticnts respec- 
tively was 0.91, 0.90, 0.80 and 0.85. These ratios bccame 0.91. 
0.89, 0.78 and 0.81, after correction for the exclusion of DCO 
cases, suggesting a small under-estimation of the deprivation 
by survival gradient in lung cancer after the exclusion of DCO 
cases. 
Another possible source of bias is the use of a single life 
table, due to the absence of social-class-specific life tables, to 
calculate expected survival in order to adjust for mortality due 
to causes other than the cancer under study. This bias could 
have resulted in over-estimation of the gradient in relative 
survival by deprivation. In general. overall mortality is higher. 
in deprived areas, and therefore the expected survival of 
patients from more deprived groups may bc over-cstimated if a 
life table from the general population is used. This may have 
resulted in under-estimation of the relative survival for the 
more deprived groups. For the affluent patient groups, ex- 
pected survival may be under-estimated and relativc survival 
over-estimated. There is some cvidencc, from a Finnish study 
on social class and breast-cancer survival, that this over- 
estimation of the deprivation-survival gradient is rather small. 
The ratio of survival between the highest and lowest social 
class was 1.10 with corrected survival rates (censoring deaths 
from other causes) and 1.12 with relative survival rates 
(Karjalainen and Pukkala, 1990). 
Furthermore, we considered the possibility that bias of the 
results arose from the use of a national rather than a regional 
life table to adjust for expected mortality. Overall mortality 
was lower in South Thames than in England and Wales as a 
whole (OPCS, 1987), so expected survival was lower and 
relative survival higher than if a regional life table had been 
used. It is unlikely, however, that differences in life expectancy 
calculated nationally or regionally would be systematic by 
deprivation category and therefore result in a bias of the 
relative survival gradient by deprivation. 
Finally, the use of a life table based on a single year (1981) 
might have caused bias of the results, but this concerns overall 
survival. It seems unlikely that the association between depri- 
vation and survival was biased, since the distribution of cases 
across years of diagnosis did not vary between deprivation 
categories. 
The stage variable that we used in this analysis is not 
identical to the TNM stage. However, the resulting reduction 
in deviancc was substantial in our analyses, suggesting reason- 
able validity of the stage variable. This was confirmed when the 
prognostic significance of this stage variable and the TNM 
stage were found to be very similar in breast-cancer cases for 
which both stage codes were available (J.-M. Lutz, personal 
communication). 
We further considered the possibility that lead-time bias 
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TABLE Ill - HAZARD RATIO (HR)  AND 95% CONFIDENCE INTERVAL (CI) BY CANCER ANDi DEPRIVATION CATEGORY, 10 MOST COMMON CANCERS, 
SOUTH THAMES RHA, 1YXO-IY8Y 
Deprivation category 
5 Slope 
(Deprived) 2 3 1 
Cancer I 
(Affluent) 
Lung 
Breast 
Colorectum? 
Bladder 
Prostate 
Stomach2 
Pancreas 
Ovary 
Uterus 
Cervix 
HR 
1.00 
1.00 
1 .oo 
1 .oo 
1.00 
1.00 
1.00 
1 .oo 
1 .oo 
1.00 
HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI) HR (9.5% CI) 
1.04 0.96-1.14 1.09 1.12 1.03-1.22) 1.13 1.01-1.26) 1.03 1.01-1.06 
0.99 10.92-1.08) 1.04 1.14 (1.05-1.25) 1.14 (1.01-1.29) 1.04 11.02-1.06) 
1.15 {1.02-1.301 1.27 1.27 [1.11-1.46) 1.47 11.22-1.76) 1.09 {1.06-1.13] 
1.02 (0.86-1.21) 1.10 (0.93-1.31j 1.24 (1.04-1.48) 1.24 (0.97-1.58) 1.07 1.02-1.12 
1.10 (0.94-1.30) 1.18 (1.00-1.40) 1.34 (1.12-1.60) 1.37 (1.07-1.76) 1.09 \1.04-1.14\ 
0.98 (0.87-1.11) 1.05 1.03 (0.91-1.17j 1.11 (0.93-1.33) 1.02 (0.99-1.06) 
1.01 0.88-1.15) 0.96 1.07(0.92-1.25 1.04 0.84-1.28 1.01 
1.48 1.09-2.02 1.46 0.97-2.20) 1.11 1.21 10 [0.91-1.34{ 0 .61 1.13 8 
1.05 jO.84-1.311 1.10 /0.81-1.50] 1.02 
1.15 I 0.94-1.40 1.29 1.17 0.96-1.44 1.35 1.07-1.71) 1.06 
'Results from models with follow-up period, deprivation category, age. (gender), and period of diagnosis.-'Also adjusted for sub-site. 
TABLE N - HAZARD RATIO (HR)  AND YSri CONFIDENCE INTERVAL (CI) BY CANCER AND,DEPRIVATION CATEGORY, 10 MOST COMMOU CANCERS, 
SOUTH THAMES RHA. lYRCLlY89 
Deprivation category 
5 Slope 
(Deprived) 2 3 J 
Cmcer 1 
(Affluent) 
HR HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI) HR (95% CI) 
1.04 096-1.12 1.09 1.13 1.04-1.22 1.11 1.00-1.23 1.03 1.01-1 06 
1.15 il:06-1.25] 1.29 1.24 [1.13-1.36] 1.43 11.27-1.621 1.09 {1.06-1:11] 
1.05 (0.91-1.22] 1.07 1.22 {1.05-1.42) 1.22 [0.99-1.51 1.06 (1.02-1.101 
Stomach2 1 .oo 0.98 {0.87-1.70] 1.04 {0.93-1.18) 1.02 [0.90-1.15] 1.11 (0.93-1.32 1.02 (0.99-1.05{ 
1.12 [0.97-1.30] 1.09 {0.94-1.28{ 1.08 (0.91-1.29) 1.12 (0.88-1.431 1.02 
1.26 0.99-1.61 1.24 (0.96-1.593 1.45 1.11-1.88 1.59 1.12-2.24) 1.11 
1.12 0.93-1.341 1.26 (1.05-1.51 1.14 0.94-1.371 1.27 1.02-1.58) 1.05 I I I 
1.00 1.02 (0.95-1.09 1.03 1.16 1.07-1.25) 1.11 1.00-1.24) 1.04 (1.02-1.06 
Prostate 1 .on 1.11 0.99-1.75 1.21 1.07-1.36) 1.37 1.20-1.56 1.34 (1.12-1.60 1.09 (1.06-1.13 
1.02 0.89-1.16 0.95 0.83-1.09 1.08 (0.93-1.26) 1.04 (0.85-1.28 1.01 
Ovary 1 .00 
Lung 1 .OO 
Breast 1 .oo 
Colorectum? 
Bladder 1.00 
Pancreas 1.00 
Uterus 1 .oo 
Cervix 1 .oo 
'Results from models with follow-up period, deprivation category, age, (gender), period of diagnosis and stage.-?Also adjusted for 
sub-site. 
TABLE V ~ DCO CASES (9)  BY CANCER AND DEPRIVATION CATEGORY, 
1 0  MOST COMMON CANCERS, SOUTfI THAMES RHA, 1980-1989 
Cdncer I 5 (Affluent) ' ' (Deprived) 
Lung 15.8 16.2 17.3 18.3 19.9 17.2 
Breast 7.9 8.9 9.0 9.4 9.4 9.4 
Colorectum 14.1 13.3 13.3 12.9 15.9 13.6 
Bladder 6.8 6.5 5.7 7.8 7.4 6.7 
Prostate 12.2 12.7 13.5 12.5 13.5 12.7 
Stomach 19.9 17.6 17.8 18.9 21.8 18.9 
Pancreas 22.5 20.1 20.8 21.1 20.3 21.1 
Ovary 11.4 11.9 13.4 13.2 12.8 12.3 
Uterus 5.9 6.2 5.6 5.7 8.3 6.0 
Cervix 5.9 5.7 5.5 7.6 4.8 6.0 
might explain part of the survival with deprivation gradient in 
this study. The analyses in this paper included an adjustment 
for stage of disease at diagnosis. As the period between origin 
of the tumour and diagnosis is associated with stage, adjust- 
ment was made, indirectly, for lead-time. Of course, residual 
confounding due to stage, and therefore lead-time, may still 
explain part of the association between deprivation and 
survival. However, if lead-time bias were the explanation, we 
would expect a larger difference in survival by deprivation in 
the first period of follow-up than in the later period, and this 
was clearly not the case in our study. The results from survival 
analyses of patients with metastatic disease showed better 
survival for patients from the most affluent group as compared 
with the most deprived group for 6 out of the 7 cancers for 
which we had observed better survival in the affluent patients; 
the only exception was lung cancer. However, the gradient in 
survival by deprivation was not consistent for any of these 
cancers and 95% CIS were rather broad for most categories. 
Only for cancers of the cervix and uterus did we find a 
substantial change in the hazard ratios for the 5 deprivation 
categories resulting from the addition of stage. Although stage 
is a very important prognostic factor in general, it cannot 
explain the gradient in survival by deprivation. This was also 
found in other studies, in which socioeconomic variation in 
survival from either breast cancer (Karjalainen and Pukkala, 
1990; Bassett and Krieger, 1986; Gordonet al., 1992) colorectal 
cancer (Wegner et al., 1982; Brenner et al., 1991), colon cancer 
(Auvinen, 1992) or cancer of the prostate (Dayal et al., 1985) 
persisted after adjustment for stage. Similar results were found 
in older studies for many cancer sites (Linden, 1969; Lipworth 
et al., 1970; Berg et al., 1977). 
Another possible explanation for the gradient in survival by 
deprivation is a difference in the management of cancer 
patients from various deprivation categories. It could be 
argued that this factor may be more important in cancers with 
an overall medium or good prognosis, and that for such cancers 
socioeconomic variation in survival would be larger. We 
calculated the ratios of survival rates of the most affluent and 
the most deprived patient group for each cancer and ranked 
these according to overall survival of the cancers. From these 
results we observed no clear gradient, which is in agreement 
with other results (Kogevinas, 1990). We did find, however, 
that the variation in survival by deprivation was absent or 
rather small in cancers with relatively poor or moderate overall 
survival (pancreas, lung, stomach, ovary, colorectum), while 
variation was larger in cancers with a fairly high overall survival 
(prostate, bladder, cervix, breast, uterus). 
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port, and immune response. In addition, determinants of 
treatment should be studied, such as adherence to guidelines 
and type of hospital. 
Our results show that the gap in survival between cancer 
patients from affluent and deprived areas is large, both in 
absolute and relative terms. We found no evidence for an 
explanation of thc survival gradient by deprivation in terms of 
large variation in stage of disease at diagnosis. Other determi- 
nants of socioeconomic variation in early detection of cancer 
by deprivation should be studied, such as the biological 
aggressiveness of a tumour, and host factors which may 
interact with the tumour. Examples of such factors are co- 
morbidity, psychological factors, nutritional status, social sup- 
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